Any Sanofi-Aventis (France) Deal For Genzyme Corporation May Take Time, At Limited Price

Wall Street Journal -- NEW YORK (Dow Jones)--French drug maker Sanofi-Aventis SA's (SNY, SAN.FR) pursuit of Genzyme Corp. (GENZ) is more likely to be a drawn out engagement rather than a shotgun wedding, and there may be other suitors.
MORE ON THIS TOPIC